MA25379A1 - Composes calcilythiques. - Google Patents

Composes calcilythiques.

Info

Publication number
MA25379A1
MA25379A1 MA26283A MA26283A MA25379A1 MA 25379 A1 MA25379 A1 MA 25379A1 MA 26283 A MA26283 A MA 26283A MA 26283 A MA26283 A MA 26283A MA 25379 A1 MA25379 A1 MA 25379A1
Authority
MA
Morocco
Prior art keywords
calcilythic
compounds
calcilythic compounds
Prior art date
Application number
MA26283A
Other languages
English (en)
Inventor
Amparo M Lago
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MA25379A1 publication Critical patent/MA25379A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/56—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and doubly-bound oxygen atoms bound to the carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Hydrogenated Pyridines (AREA)
MA26283A 1999-02-02 2001-08-01 Composes calcilythiques. MA25379A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11824099P 1999-02-02 1999-02-02

Publications (1)

Publication Number Publication Date
MA25379A1 true MA25379A1 (fr) 2002-04-01

Family

ID=22377367

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26283A MA25379A1 (fr) 1999-02-02 2001-08-01 Composes calcilythiques.

Country Status (24)

Country Link
US (1) US6417215B1 (fr)
EP (1) EP1148876A4 (fr)
JP (1) JP2002536330A (fr)
KR (1) KR20010093285A (fr)
CN (1) CN1346269A (fr)
AP (1) AP2001002220A0 (fr)
AU (1) AU3480200A (fr)
BG (1) BG105847A (fr)
BR (1) BR0007922A (fr)
CA (1) CA2361589A1 (fr)
CO (1) CO5251439A1 (fr)
CZ (1) CZ20012797A3 (fr)
EA (1) EA200100854A1 (fr)
HK (1) HK1042036A1 (fr)
HU (1) HUP0200121A3 (fr)
ID (1) ID29533A (fr)
IL (1) IL144470A0 (fr)
MA (1) MA25379A1 (fr)
NO (1) NO20013769L (fr)
OA (1) OA11757A (fr)
PE (1) PE20001456A1 (fr)
SK (1) SK10982001A3 (fr)
WO (1) WO2000045816A1 (fr)
ZA (1) ZA200106298B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60136187D1 (de) 2000-08-11 2008-11-27 Japan Tobacco Inc Calciumrezeptor-antagonisten
AU2002230579A1 (en) * 2000-10-25 2002-05-06 Smithkline Beecham Corp Calcilytic compounds
US6864267B2 (en) * 2001-07-16 2005-03-08 Smithkline Beecham Corporation Calcilytic compounds
TWI316511B (en) 2002-11-26 2009-11-01 Smithkline Beecham Corp Calcilytic compounds
WO2004069793A2 (fr) 2003-01-28 2004-08-19 Bristol-Myers Squibb Company Nouveaux amines cycliques substitues en position 2 comme modulateurs du recepteur de detection de calcium
US7205322B2 (en) 2003-02-12 2007-04-17 Bristol-Myers Squibb Company Thiazolidine compounds as calcium sensing receptor modulators
DK1619180T3 (da) * 2003-04-23 2010-03-29 Japan Tobacco Inc CaSR-antagonist
WO2004106280A1 (fr) * 2003-05-28 2004-12-09 Japan Tobacco Inc. Antagoniste de casr
US7265145B2 (en) 2003-05-28 2007-09-04 Bristol-Myers Squibb Company Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method
EP1964548A1 (fr) * 2007-03-02 2008-09-03 Novartis AG Compositions pharmaceutiques comprenant un agent calcilytique
RU2502730C2 (ru) 2008-06-05 2013-12-27 Асахи Касеи Фарма Корпорейшн Сульфонамидные соединения и их применение
WO2010103429A1 (fr) 2009-03-10 2010-09-16 Pfizer Inc. Dérivés de l'acide 1,1-(diméthyl-éthylamino)-2-hydroxy-propoxy]-éthyl}-3-méthyl-biphényl-4-carboxylique utiles en tant qu'antagonistes des récepteurs du calcium
GB201217330D0 (en) * 2012-09-28 2012-11-14 Univ Cardiff Therapeutic for treating inflammatory lung disorders
US20220288076A1 (en) * 2019-08-13 2022-09-15 Dongguk University Industry-Academic Cooperation Foundation Pharmaceutical composition for improving or treating post-surgical hypoparathyroidism and treatment method using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97219A (en) 1990-02-19 1995-12-08 Ciba Geigy Ag Biphenyl substituted aliphatic amino compounds process for their preparation and pharmaceutical compositions containing them
DE4102024A1 (de) 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE69733649T2 (de) * 1996-04-09 2006-05-18 NPS Pharmaceuticals, Inc., Salt Lake City Calcylitische verbindungen
UY24949A1 (es) * 1997-04-08 2001-04-30 Smithkline Beecham Corp Compuestos calcilíticos

Also Published As

Publication number Publication date
NO20013769L (no) 2001-09-26
EA200100854A1 (ru) 2002-02-28
CO5251439A1 (es) 2003-02-28
PE20001456A1 (es) 2001-01-28
SK10982001A3 (sk) 2001-12-03
CZ20012797A3 (cs) 2002-01-16
EP1148876A1 (fr) 2001-10-31
HUP0200121A3 (en) 2002-11-28
HUP0200121A2 (hu) 2002-05-29
CN1346269A (zh) 2002-04-24
AU3480200A (en) 2000-08-25
BG105847A (en) 2002-04-30
NO20013769D0 (no) 2001-08-01
AP2001002220A0 (en) 2001-09-30
OA11757A (en) 2005-07-19
KR20010093285A (ko) 2001-10-27
WO2000045816A1 (fr) 2000-08-10
BR0007922A (pt) 2001-11-06
CA2361589A1 (fr) 2000-08-10
IL144470A0 (en) 2002-05-23
ZA200106298B (en) 2002-10-18
EP1148876A4 (fr) 2003-07-23
ID29533A (id) 2001-09-06
US6417215B1 (en) 2002-07-09
HK1042036A1 (zh) 2002-08-02
JP2002536330A (ja) 2002-10-29

Similar Documents

Publication Publication Date Title
TR200000520A3 (tr) 4-Fenil-piridin türevleri.
MA25499A1 (fr) Contacteur-disjoncteur.
BR0011566B1 (pt) bolsa flexìvel.
BR0014932B1 (pt) conjunto de retenção.
MA26849A1 (fr) 4-pyridinyle-n-acyl-l-phenylalanines.
MA25379A1 (fr) Composes calcilythiques.
ITBO990359A0 (it) Elettromandrino .
MXPA01011760A (es) Compuestos novedosos de difeniletileno.
DE60029755D1 (de) Congawandschutz.
IT1311433B1 (it) Lavapiatti.
ITBO990358A0 (it) Elettromandrino .
NL1011488A1 (nl) Hoofdtelefoon-microfoon-combinatie.
ES1044367Y (es) Piñata mejorada.
ES1044838Y (es) Friegasuelos.
ITSS990004V0 (it) Piramide - ricordo.
ES1042809Y (es) Esponja-estropajo mejorado.
IT1313922B1 (it) Elettromandrino perfezionato.
ITTO990195V0 (it) Soletta sottopiede.
ES1042340Y (es) Contenedor.
ES1042445Y (es) Guardabolsas.
ES1044797Y (es) Collar-bozal antitiro.
ES1044580Y (es) Humidificador-fitosanitario.
IT247637Y1 (it) Tritapepe.
ES1044490Y (es) Piñata.
ES1043620Y (es) Urna-columbario.